These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9351599)

  • 21. Empiric antimicrobial therapy for Gram-negative sepsis: back to the future.
    Leekha S; Standiford HC
    Crit Care Med; 2011 Aug; 39(8):1995-6. PubMed ID: 21768802
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center.
    Nag VL; Ayyagari A; Venkatesh V; Dash NR; Ghar M; Prasad KN
    J Commun Dis; 2005 Dec; 37(4):281-7. PubMed ID: 17278658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance--experience in a tertiary care hospital in south India.
    Subbalaxmi MV; Lakshmi V; Lavanya V
    J Assoc Physicians India; 2010 Dec; 58 Suppl():18-22. PubMed ID: 21568007
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftaroline fosamil: drug profile and clinical data.
    Kanafani ZA
    Future Microbiol; 2011 Jan; 6(1):9-18. PubMed ID: 21162631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
    Kiem S; Schentag JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):51-67. PubMed ID: 16508882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peptide antibiotics].
    Debbia EA
    Recenti Prog Med; 2000 Mar; 91(3):106-8. PubMed ID: 10763339
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hospital infection and resistance to antibiotics at a pediatric intensive care unit].
    Velasco Jabalquinto MJ; Fernández-Crehuet Navajas R; Real Gallego I; Pérez Navero JL; Romanos Lezcano A
    An Esp Pediatr; 1988 Aug; 29(2):122-6. PubMed ID: 3056148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM; Zhou JD; Wu Y; Qi Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriological profile of neonatal septicemia.
    Sharma PP; Halder D; Dutta AK; Dutta R; Bhatnagar S; Bali A; Kumari S
    Indian Pediatr; 1987 Nov; 24(11):1011-7. PubMed ID: 3450639
    [No Abstract]   [Full Text] [Related]  

  • 31. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacteriological surveillance in a burn intensive care unit and the analysis of bacterial resistance to antibiotics].
    Chen L; Deng SL; Liang JW; Zhang YH; Liu JW
    Zhonghua Shao Shang Za Zhi; 2005 Aug; 21(4):270-2. PubMed ID: 16185410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico.
    Llaca-Díaz JM; Mendoza-Olazarán S; Camacho-Ortiz A; Flores S; Garza-González E
    Chemotherapy; 2012; 58(6):475-81. PubMed ID: 23548324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics".
    Bergan T; Bruun JN; Digranes A; Lingaas E; Melby KK; Sander J
    Scand J Infect Dis Suppl; 1997; 103():1-36. PubMed ID: 9253777
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in antibiotic treatment.
    de Roux A; Lode H
    Infect Dis Clin North Am; 2003 Dec; 17(4):739-51. PubMed ID: 15008596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
    J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.